Biopharmaceutical Analysis & Statistics in North America Countries, July 2013 (p7)

You might be interested in: Protein, Biomedical, Antibody, more »

181-210 of about 200 reports

Purchase Reports From Reputable Market Research Publishers

Immunotope, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Immunotope, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Immunotope, Inc. (Immunotope) is a biotechnology company. It develops immunotherapy products for the prevention and treatment of cancer and chronic viral infections. Immunotope's product IMT-1012 ...

  • Industries : Biopharmaceutical
  • Countries : United States
Fujifilm Diosynth Biotechnologies U.S.A., Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Fujifilm Diosynth Biotechnologies U.S.A., Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Fujifilm Diosynth Biotechnologies (Diosynth) is a biologics contract manufacturer. The company provides cGMP manufacturing services. Its manufacturing capabilities include monoclonal antibodies, ...

  • Industries : Biopharmaceutical
  • Countries : United States
Calypte Biomedical Corporation (CBMC) - Medical Equipment - Deals and Alliances Profile

Calypte Biomedical Corporation (CBMC) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Calypte Biomedical Corporation (Calypte) is a diagnostic company. It carries out the development, manufacture and marketing of in-vitro testing algorithms for improved diagnosis of HIV infection ...

  • Industries : Biopharmaceutical
  • Countries : United States
Biopharmaceuticals - A Global Market Overview

Biopharmaceuticals - A Global Market Overview

  • $ 4 500
  • Industry report
  • July 2013
  • by Industry Experts

`The pharmaceutical R&D pipeline and industry have been witnessing greater degree of dependence on biopharmaceuticals. Development of these products is being undertaken by a growing number of players in ...

  • Industries : Biopharmaceutical
  • Countries : World, United States
Charting the Biosimilar and Biobetter Development Pipeline (2013)

Charting the Biosimilar and Biobetter Development Pipeline (2013)

  • $ 1 950
  • Industry report
  • July 2013
  • by Firstword Pharma

If you need to understand the important biosimilar and biobetter drug developments worldwide then this report is critical. The promise of biosimilars has been great but beyond the first wave of products ...

  • Industries : Biopharmaceutical
  • Countries : United States, World
Omrix Biopharmaceuticals, Inc. SWOT Analysis, Strategy, Revenues and Profits

Omrix Biopharmaceuticals, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • June 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States, Israel
Global Vaccine Market to 2017 - Market Size, Growth, and Forecasts in Over 70 Countries

Global Vaccine Market to 2017 - Market Size, Growth, and Forecasts in Over 70 Countries

  • $ 2 488
  • Industry report
  • June 2013
  • by MarketSizeInfo

Global Vaccine Market to 2017 - Market Size, Growth and Forecasts in Over 70 Countries is a comprehensive publication that enables readers the critical perspectives to be able to evaluate the world market ...

  • Industries : Biopharmaceutical
  • Countries : World, Europe, Asia, South America, Czech Republic, South Korea, Philippines, Africa, Australia, Argentina, United States, United Kingdom, Netherlands, Macedonia, Lithuania, Sri Lanka, Singapore, Kazakhstan, Indonesia, Bangladesh, Azerbaijan, South Africa, Uruguay, Ecuador, Chile, Colombia, Bolivia, Panama, Mexico, Canada, Ukraine, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Russian Federation, Romania, Portugal, Poland, Norway, Moldova, Republic Of, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Bulgaria, Belgium, Austria, Vietnam, Thailand, Pakistan, Nepal, Mongolia, Malaysia, Lebanon, Jordan, Japan, India, China, Georgia, Armenia, Sudan, Senegal, Nigeria, Morocco, Ghana, Ethiopia, Egypt, Kyrgyz Republic (kyrgyzstan), Peru, Oman, Iran, North America, Oceania
Biosimilar Defensive Plays - Assessing the options

Biosimilar Defensive Plays - Assessing the options

  • $ 495
  • Industry report
  • June 2013
  • by Firstword Pharma

Although biological therapeutics have developed into an increasingly valuable segment of the pharmaceutical market, the commercial impact of biosimilar products has, to date, been fairly insignificant. ...

  • Industries : Biopharmaceutical
  • Countries : United States, United Kingdom, Europe
Antibody Drug Conjugates Market, 2012-2023

Antibody Drug Conjugates Market, 2012-2023

  • $ 1 699
  • Industry report
  • May 2013
  • by Roots Analysis Private Ltd.

Antibody Drug Conjugates (ADC) are a new class of biologic therapeutics. These are complex molecules comprising of an antibody linked to few cytotoxin molecules through linker technology. This class of ...

  • Industries : Biopharmaceutical
  • Countries : United States
PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013

PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013

  • $ 2 995
  • Industry report
  • May 2013
  • by Global Data

PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013 Summary GlobalData's "PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, ...

  • Industries : Biopharmaceutical
  • Countries : South Korea, India, World, China, United States, Japan, Asia, Europe
QuantRx Biomedical Corporation (QTXB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

QuantRx Biomedical Corporation (QTXB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2013
  • by Global Data

Summary QuantRx Biomedical Corporation (QuantRx Biomedical) is a medical device company engaged in the development of products for advanced diagnosis of serious disease and health conditions. QuantRx Biomedical's ...

  • Industries : Biopharmaceutical
  • Countries : United States
Sports Nutrition Market Overview in Canada

Sports Nutrition Market Overview in Canada

  • $ 898
  • Industry report
  • May 2013
  • by Euromonitor International

During 2010, retail sales of sports nutrition products grew 3% to reach C$122 million in current value terms. Sports nutrition registered slower growth than in previous years of the review period, largely ...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : Canada
Competitor Analysis: Antibody-Drug Conjugates (ADC)

Competitor Analysis: Antibody-Drug Conjugates (ADC)

  • $ 792
  • Industry report
  • April 2013
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about Antibody-Drug Conjugates (ADC) / Immunoconjugates provides a competitor evaluation in the field of tumor targeting antibodies conjugated ...

  • Industries : Biopharmaceutical
  • Countries : United States
ImClone LLC - Strategic SWOT Analysis Review

ImClone LLC - Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • March 2013
  • by Global Data

Summary ImClone LLC (ImClone) is a biopharmaceutical company. It undertakes the development and manufacturing of targeted biologic treatments for cancer. The company's product pipeline has several investigational ...

  • Industries : Biopharmaceutical
  • Countries : United States
Enzon Pharmaceuticals, Inc. : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Report

Enzon Pharmaceuticals, Inc. : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Report

  • $ 125
  • Company report
  • January 2013
  • by ICD Research

Synopsis ICD Research's "Enzon Pharmaceuticals, Inc. : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. ...

  • Industries : Biopharmaceutical
  • Countries : United States
Combinent BioMedical Systems, Inc. - Medical Equipment - Deals and Alliances Profile

Combinent BioMedical Systems, Inc. - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2013
  • by Global Data

Summary Combinent BioMedical Systems, Inc. (Combinent) is a bio-pharmaceutical company, based in the US. It develops and markets novel women healthcare products to the healthcare market. The company develops ...

  • Industries : Biopharmaceutical
  • Countries : United States
The 2013-2018 Outlook for Protein Shakes in the United States

The 2013-2018 Outlook for Protein Shakes in the United States

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This econometric study covers the latent demand outlook for protein shakes across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings ...

  • Industries : Biopharmaceutical, Sport Nutritional
  • Countries : United States
Nabi Biopharmaceuticals - SWOT, Strategy and Corporate Finance Report

Nabi Biopharmaceuticals - SWOT, Strategy and Corporate Finance Report

  • $ 175
  • Company report
  • January 2013
  • by MarketLine

Nabi Biopharmaceuticals - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product ...

  • Industries : Biopharmaceutical
  • Countries : United States
Accentia Biopharmaceuticals, Inc. - Product Pipeline Review - 2012

Accentia Biopharmaceuticals, Inc. - Product Pipeline Review - 2012

  • $ 1 500
  • Industry report
  • September 2012
  • by Global Markets Direct

Accentia Biopharmaceuticals, Inc. - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, ?Accentia Biopharmaceuticals, Inc. - Product Pipeline Review - 2012? provides ...

  • Industries : Biopharmaceutical
  • Countries : United States, World
The New Generation of Antibody Therapeutics: Current Status and Future Prospects - Overview

The New Generation of Antibody Therapeutics: Current Status and Future Prospects - Overview

  • $ 2 495
  • Industry report
  • June 2012
  • by CHI Insight Pharma Reports

Antibody sales are predicted to reach $50 billion this year. This Insight Pharma Report focuses on recent developments in the therapeutic antibody field and new technologies built on the foundations of ...

  • Industries : Biopharmaceutical
  • Countries : United States
InterMune, Inc. SWOT

InterMune, Inc. SWOT

  • $ 175
  • Company report
  • June 2012
  • by MarketLine

examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. InterMune is a biotech industry player focused on ...

  • Industries : Biopharmaceutical
  • Countries : United States
Purchasing Trends in the Research Antibodies Market

Purchasing Trends in the Research Antibodies Market

  • $ 10 000
  • Industry report
  • May 2012
  • by Frost & Sullivan

This study is based on input from 1,155 laboratory personnel who either participate in their laboratory's purchase of antibodies or are users of antibodies. Most survey participants are located in the ...

  • Industries : Biopharmaceutical
  • Countries : United States
9th Annual Report and Survey of Biopharmaceutical Manufacturing

9th Annual Report and Survey of Biopharmaceutical Manufacturing

  • $ 865
  • Industry report
  • May 2012
  • by BioPlan Associates, Inc.

Improve your decision-making in biomanufacturing capacity, production, and performance with this essential reference tool. With over 200 data graphs and tables with in-depth research on global biomanufacturers, ...

  • Industries : Biopharmaceutical
  • Countries : Europe, United States
Global Biosimilars Industry

Global Biosimilars Industry

  • $ 4 500
  • Industry report
  • April 2012
  • by Global Industry Analysts

This report analyzes the worldwide markets for Biosimilars in US$ Million. The report provides separate comprehensive analytics for US, Europe, and Japan. Annual estimates and forecasts are provided fo ...

  • Industries : Biopharmaceutical
  • Countries : World, India, Europe, United States, Japan, France, Germany, Asia, United Kingdom, North America
Enzymes: Canada : Focus report

Enzymes: Canada : Focus report

  • $ 850
  • Industry report
  • April 2012
  • by Freedonia Focus

This report discusses enzyme demand in Canada for the years 2005 and 2010, with forecasts for 2015. Topics covered include overview of products; overview of markets; economic trends and supply and demand ...

  • Industries : Biopharmaceutical
  • Countries : Canada
Enzymes: Mexico : Focus report

Enzymes: Mexico : Focus report

  • $ 850
  • Industry report
  • April 2012
  • by Freedonia Focus

This report discusses enzyme demand in Mexico for the years 2005 and 2010, with forecasts for 2015. Topics covered include overview of products; overview of markets; economic trends and supply and demand ...

  • Industries : Biopharmaceutical
  • Countries : Mexico
Strategic Analysis of the U.S. Research Antibodies Market

Strategic Analysis of the U.S. Research Antibodies Market

  • $ 6 000
  • Industry report
  • March 2012
  • by Frost & Sullivan

This research service evaluates the U.S. research antibodies market during the 2009 to 2016 time period. The research antibodies market includes all antibodies sold for research use only to be used as ...

  • Industries : Biopharmaceutical
  • Countries : United States
Investment Confidence Among Laboratory Decision Makers

Investment Confidence Among Laboratory Decision Makers

  • $ 10 000
  • Industry report
  • March 2012
  • by Frost & Sullivan

The study investigates investment decisions of healthcare-related laboratory decision makers. It shows that 2011 was tumultuous for the laboratory industry. In comparison, the outlook for 2012 looks only ...

  • Industries : Biopharmaceutical
  • Countries : United States
Neose Technologies, Inc. (Inactive): Pharmaceuticals and Healthcare Company Profile, SWOT Report

Neose Technologies, Inc. (Inactive): Pharmaceuticals and Healthcare Company Profile, SWOT Report

  • $ 125
  • Company report
  • March 2012
  • by ICD Research

Synopsis ICD Research's "Neose Technologies, Inc. (Inactive): Pharmaceuticals and Healthcare Company Profile, SWOT Report" contains in depth information and data about the company and its operations. ...

  • Industries : Biopharmaceutical
  • Countries : United States
BioExx Specialty Proteins Ltd.: Ingredients Company Profile, SWOT & Financial Report

BioExx Specialty Proteins Ltd.: Ingredients Company Profile, SWOT & Financial Report

  • $ 125
  • Company report
  • March 2012
  • by Canadean Ltd

Synopsis Canadean's "BioExx Specialty Proteins Ltd.: Ingredients Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile contains ...

  • Industries : Biopharmaceutical
  • Countries : Canada

4 Companies

Read our Company Profiles

Johnson and Johnson

United States

Biogen Idec

United States

GlaxoSmithKline P.L.C.

United States

Amgen Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.